MWNA
CLVS

Marshall Wace North America’s Clovis Oncology, Inc. CLVS Stock Holding History

Marshall Wace North America’s Portfolio CLVS Stock Details CLVS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
2018
Q4 		$4.9M Buy
2018
Q3 		$1.43M Buy
2018
Q1 		– Sell
2017
Q4 		$32.5M Buy
2017
Q3 		$30M Buy
2017
Q2 		$11.5M Buy
2017
Q1 		$6.15M Buy